(PRESS RELEASE) JACKSONVILLE, FL – Johnson & Johnson Vision, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies, announced clinical data from the latest in myopia research at the American Academy of Optometry’s virtual annual meeting (Academy 2020). Investigators will also reveal findings that demonstrate how ACUVUE OASYS 1-Day with Hydraluxe Technology Contact Lenses reduced dry eye symptoms in contact lens wearers who are symptomatic in their habitual lens wear.
“Myopia is a chronic and sometimes progressive disease that poses one of the biggest threats to eye health, with children 12 and younger being the most vulnerable,” said Thomas Swinnen, president, North America, Johnson & Johnson Vision Care, Inc. “Johnson & Johnson Vision is taking a holistic approach in collaboration with various universities and research institutes. Together, we are working to deliver new, evidence-based solutions for patients with myopia and their care providers.”
“Over the next few decades, half of the world’s population is expected to be myopic, and it is estimated that one billion will have high myopia,” said Noel Brennen, BOptom, MScOptom, PhD, FAAO and global lead, Myopia Control, Johnson & Johnson Vision. “In Singapore, for example, one in two children develop myopia by the age of 12, and 75% of teenagers are myopic and rely on glasses. Left unchecked, in some patients, myopia can lead to blindness or other eye health conditions that can severely impact vision and overall well-being.”
Johnson & Johnson Vision researchers highlight findings from several studies in myopia at Academy 2020, including:
- Risk of Becoming Highly Myopic (< -5.00 D) By Age of First Spectacles in Children
Noel Brennan, Xu Cheng, Youssef Toubouti, Mark Bullimore - We Can’t Predict Future Axial Elongation in Myopic Children with Confidence
Alex Nixon, Xu Cheng, Youssef Toubouti, Mark Bullimore, Noel Brennan - A Model of Visual Impairment as a Function of Age and Axial Length
Mark Bullimore, Noel Brennan - Preliminary Analysis of an Age-Dependent Universal Calculator for Myopia Prevalence
Noel Brennan, Nicole Franklin, Xu Cheng, Youssef Toubouti, Mark Bullimore - Repeatability of Axial Length Measurement is Superior to Repeatability of Refractive Error
Mark Bullimore, Noel Brennan - Further Evidence That Absolute Myopia Control Treatment Effect Is Constant Across the Progression Range: Analysis of Standard Deviations
Alex Nixon, Xu Cheng, Youssef Toubouti, Mark Bullimore, Noel Brennan
Johnson & Johnson Vision researchers also presented data from an integrated retrospective analysis of three trials including 107 symptomatic dry eye contact lens patients revealing clinically meaningful and statistically significant (p<0.0001) difference in comfort when they switched to ACUVUE OASYS 1-Day with Hydraluxe Technology Contact Lenses.
“After 2 weeks of wear, ACUVUE OASYS 1-Day significantly reduced dryness symptoms and improved comfort among both daily disposable and reusable contact lens wearers who were symptomatic in their habitual lens,” noted Meredith Bishop, OD, MS, FAAO, senior principal research optometrist, Johnson & Johnson Vision. “Based on the findings of this retrospective analysis, habitual wearers who suffer from dry eye symptoms during contact lens wear and contact lens discomfort may significantly benefit from switching to ACUVUE OASYS 1-Day with Hydraluxe Technology.”
Additional presentations include:
- Integrated Retrospective Analysis of Three Trials Evaluating ACUVUE OASYS 1-Day with HydraLuxe Technology in a Symptomatic Population
Meredith Bishop, Chung-kai Sun, Youssef Toubouti, Elizabeth Dow, Caroline Blackie, Chantal Coles-Brennan, Annabelle Gallois-Bernos - Reduction of Dry Eye Symptoms with Daily Disposable Lens Wear with Senofilcon A
(ACUVUE OASYS 1-Day with Hydraluxe Technology)
Elizabeth Dow, Ping Chen, Jie Xu, Samira Soleymani, Meredith Bishop, Youssef Toubouti, Caroline Blackie, Annabelle Gallois-Bernos
ACUVUE is the most trusted brand for eye doctors globally , and has built a legacy by making contact lenses that are unbeaten in comfort across 44 clinical studies. The Johnson & Johnson Vision team is launching a virtual experience where registered attendees can view interactive videos offering peer-to-peer perspectives on skills and best practices within the “new normal” of the optometric community. Johnson & Johnson Vision Consultants are also available via live chat to share more about the portfolio of products and services and ACUVUE Take Comfort promise.
For more information about Johnson & Johnson Vision at Academy 2020, visit here.